Retail Drug
Retail Drug

Retail Drug Comprehensive Study by Type (Generic Drug, OTC Drug, Others), Application (Hospital, Clinic, Hoem Use) Players and Region - Global Market Outlook to 2024

Retail Drug Market Segmented into XX Submarkets. | Forecast Years: 2019- 2024  

Aug 2019 Edition 224 Pages 174 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Scope of the Study
The retail drug is defined as the store which sells both medicines as well as health care products. Customers can easily buy the product from over-the-counter and prescription medication at a drug store. The Retail drug has witnessed growth at a noteworthy rate over the past few years due to the rising number of the average age of the consumer and rising aging population across the world is likely to be a major driver for the global retail drug market over the forecast period.

The market study is being classified by Type (Generic Drug, OTC Drug and Others), by Application (Hospital, Clinic and Hoem Use) and major geographies with country level break-up.

CVS Caremark (United States), Rite Aid (United States), Target Corporation (United States), Walgreens (United States), Walmart (United States), Health Mart Pharmacy (United States), The Kroger Co. (United States), Good Neighbor Pharmacy (United States), Safeway Inc. (United States), Kmart Corporation (United States) and Hy-Vee (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Giant Eagl (United States).

The retail drug market is highly fragmented with the presence of various players. Some of the leading players in the retail drug market are CVS Caremark (United States), Rite Aid (United States), Target Corporation (United States), among others Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Retail Drug market throughout the predicted period.

Segment Analysis
AdvanceMarketAnalytics has segmented the market of Global Retail Drug market by Type, Application and Region.

On the basis of geography, the market of Retail Drug has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2018.

Market Drivers
  • Growing Old Age Population and Increasing Health Consciousness across the World
  • Increasing Disposal Income among Middle-Class Families and Demand for Better Health Care System

Market Trend
  • Increasing Number of Customer from Online Drug Retailer

Restraints
  • Stringent Government Regulation Regarding Retail Drug Products

Opportunities
  • Growing Demand from Emerging Economics such as China, India, Brazil, Philippines, among others
  • Government Initiative to Promote Retail Drug in Developing Countries

Challenges
  • Growing Competition and Consolidation of Retail Pharmacy Chains
  • Manage Customer Service and Unpleasant Situations in Retail Drug Store





Key Target Audience
Retail Drug Companies, Research and Development (R&D) Companies, Research Organization, Federal Agencies and Others

Customization in the Report Available:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Type
  • Generic Drug
  • OTC Drug
  • Others
By Application
  • Hospital
  • Clinic
  • Hoem Use
By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Old Age Population and Increasing Health Consciousness across the World
      • 3.2.2. Increasing Disposal Income among Middle-Class Families and Demand for Better Health Care System
    • 3.3. Market Challenges
      • 3.3.1. Growing Competition and Consolidation of Retail Pharmacy Chains
      • 3.3.2. Manage Customer Service and Unpleasant Situations in Retail Drug Store
    • 3.4. Market Trends
      • 3.4.1. Increasing Number of Customer from Online Drug Retailer
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Retail Drug, by Type, Application and Region (value, volume and price ) (2013-2018)
    • 5.1. Introduction
    • 5.2. Global Retail Drug (Value)
      • 5.2.1. Global Retail Drug by: Type (Value)
        • 5.2.1.1. Generic Drug
        • 5.2.1.2. OTC Drug
        • 5.2.1.3. Others
      • 5.2.2. Global Retail Drug by: Application (Value)
        • 5.2.2.1. Hospital
        • 5.2.2.2. Clinic
        • 5.2.2.3. Hoem Use
      • 5.2.3. Global Retail Drug Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
    • 5.3. Global Retail Drug (Volume)
      • 5.3.1. Global Retail Drug by: Type (Volume)
        • 5.3.1.1. Generic Drug
        • 5.3.1.2. OTC Drug
        • 5.3.1.3. Others
      • 5.3.2. Global Retail Drug by: Application (Volume)
        • 5.3.2.1. Hospital
        • 5.3.2.2. Clinic
        • 5.3.2.3. Hoem Use
      • 5.3.3. Global Retail Drug Region
        • 5.3.3.1. South America
          • 5.3.3.1.1. Brazil
          • 5.3.3.1.2. Argentina
          • 5.3.3.1.3. Rest of South America
        • 5.3.3.2. Asia Pacific
          • 5.3.3.2.1. China
          • 5.3.3.2.2. Japan
          • 5.3.3.2.3. India
          • 5.3.3.2.4. South Korea
          • 5.3.3.2.5. Taiwan
          • 5.3.3.2.6. Australia
          • 5.3.3.2.7. Rest of Asia-Pacific
        • 5.3.3.3. Europe
          • 5.3.3.3.1. Germany
          • 5.3.3.3.2. France
          • 5.3.3.3.3. Italy
          • 5.3.3.3.4. United Kingdom
          • 5.3.3.3.5. Netherlands
          • 5.3.3.3.6. Rest of Europe
        • 5.3.3.4. MEA
          • 5.3.3.4.1. Middle East
          • 5.3.3.4.2. Africa
        • 5.3.3.5. North America
          • 5.3.3.5.1. United States
          • 5.3.3.5.2. Canada
          • 5.3.3.5.3. Mexico
    • 5.4. Global Retail Drug (Price)
      • 5.4.1. Global Retail Drug by: Type (Price)
  • 6. Retail Drug: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2018)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. CVS Caremark (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Rite Aid (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Target Corporation (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Walgreens (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Walmart (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Health Mart Pharmacy (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. The Kroger Co. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Good Neighbor Pharmacy (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Safeway Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Kmart Corporation (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Hy-Vee (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Retail Drug Sale, by Type, Application and Region (value, volume and price ) (2019-2024)
    • 7.1. Introduction
    • 7.2. Global Retail Drug (Value)
      • 7.2.1. Global Retail Drug by: Type (Value)
        • 7.2.1.1. Generic Drug
        • 7.2.1.2. OTC Drug
        • 7.2.1.3. Others
      • 7.2.2. Global Retail Drug by: Application (Value)
        • 7.2.2.1. Hospital
        • 7.2.2.2. Clinic
        • 7.2.2.3. Hoem Use
      • 7.2.3. Global Retail Drug Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
    • 7.3. Global Retail Drug (Volume)
      • 7.3.1. Global Retail Drug by: Type (Volume)
        • 7.3.1.1. Generic Drug
        • 7.3.1.2. OTC Drug
        • 7.3.1.3. Others
      • 7.3.2. Global Retail Drug by: Application (Volume)
        • 7.3.2.1. Hospital
        • 7.3.2.2. Clinic
        • 7.3.2.3. Hoem Use
      • 7.3.3. Global Retail Drug Region
        • 7.3.3.1. South America
          • 7.3.3.1.1. Brazil
          • 7.3.3.1.2. Argentina
          • 7.3.3.1.3. Rest of South America
        • 7.3.3.2. Asia Pacific
          • 7.3.3.2.1. China
          • 7.3.3.2.2. Japan
          • 7.3.3.2.3. India
          • 7.3.3.2.4. South Korea
          • 7.3.3.2.5. Taiwan
          • 7.3.3.2.6. Australia
          • 7.3.3.2.7. Rest of Asia-Pacific
        • 7.3.3.3. Europe
          • 7.3.3.3.1. Germany
          • 7.3.3.3.2. France
          • 7.3.3.3.3. Italy
          • 7.3.3.3.4. United Kingdom
          • 7.3.3.3.5. Netherlands
          • 7.3.3.3.6. Rest of Europe
        • 7.3.3.4. MEA
          • 7.3.3.4.1. Middle East
          • 7.3.3.4.2. Africa
        • 7.3.3.5. North America
          • 7.3.3.5.1. United States
          • 7.3.3.5.2. Canada
          • 7.3.3.5.3. Mexico
    • 7.4. Global Retail Drug (Price)
      • 7.4.1. Global Retail Drug by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Retail Drug: by Type(USD Million)
  • Table 2. Retail Drug Generic Drug , by Region USD Million (2013-2018)
  • Table 3. Retail Drug OTC Drug , by Region USD Million (2013-2018)
  • Table 4. Retail Drug Others , by Region USD Million (2013-2018)
  • Table 5. Retail Drug: by Application(USD Million)
  • Table 6. Retail Drug Hospital , by Region USD Million (2013-2018)
  • Table 7. Retail Drug Clinic , by Region USD Million (2013-2018)
  • Table 8. Retail Drug Hoem Use , by Region USD Million (2013-2018)
  • Table 9. South America Retail Drug, by Country USD Million (2013-2018)
  • Table 10. South America Retail Drug, by Type USD Million (2013-2018)
  • Table 11. South America Retail Drug, by Application USD Million (2013-2018)
  • Table 12. Brazil Retail Drug, by Type USD Million (2013-2018)
  • Table 13. Brazil Retail Drug, by Application USD Million (2013-2018)
  • Table 14. Argentina Retail Drug, by Type USD Million (2013-2018)
  • Table 15. Argentina Retail Drug, by Application USD Million (2013-2018)
  • Table 16. Rest of South America Retail Drug, by Type USD Million (2013-2018)
  • Table 17. Rest of South America Retail Drug, by Application USD Million (2013-2018)
  • Table 18. Asia Pacific Retail Drug, by Country USD Million (2013-2018)
  • Table 19. Asia Pacific Retail Drug, by Type USD Million (2013-2018)
  • Table 20. Asia Pacific Retail Drug, by Application USD Million (2013-2018)
  • Table 21. China Retail Drug, by Type USD Million (2013-2018)
  • Table 22. China Retail Drug, by Application USD Million (2013-2018)
  • Table 23. Japan Retail Drug, by Type USD Million (2013-2018)
  • Table 24. Japan Retail Drug, by Application USD Million (2013-2018)
  • Table 25. India Retail Drug, by Type USD Million (2013-2018)
  • Table 26. India Retail Drug, by Application USD Million (2013-2018)
  • Table 27. South Korea Retail Drug, by Type USD Million (2013-2018)
  • Table 28. South Korea Retail Drug, by Application USD Million (2013-2018)
  • Table 29. Taiwan Retail Drug, by Type USD Million (2013-2018)
  • Table 30. Taiwan Retail Drug, by Application USD Million (2013-2018)
  • Table 31. Australia Retail Drug, by Type USD Million (2013-2018)
  • Table 32. Australia Retail Drug, by Application USD Million (2013-2018)
  • Table 33. Rest of Asia-Pacific Retail Drug, by Type USD Million (2013-2018)
  • Table 34. Rest of Asia-Pacific Retail Drug, by Application USD Million (2013-2018)
  • Table 35. Europe Retail Drug, by Country USD Million (2013-2018)
  • Table 36. Europe Retail Drug, by Type USD Million (2013-2018)
  • Table 37. Europe Retail Drug, by Application USD Million (2013-2018)
  • Table 38. Germany Retail Drug, by Type USD Million (2013-2018)
  • Table 39. Germany Retail Drug, by Application USD Million (2013-2018)
  • Table 40. France Retail Drug, by Type USD Million (2013-2018)
  • Table 41. France Retail Drug, by Application USD Million (2013-2018)
  • Table 42. Italy Retail Drug, by Type USD Million (2013-2018)
  • Table 43. Italy Retail Drug, by Application USD Million (2013-2018)
  • Table 44. United Kingdom Retail Drug, by Type USD Million (2013-2018)
  • Table 45. United Kingdom Retail Drug, by Application USD Million (2013-2018)
  • Table 46. Netherlands Retail Drug, by Type USD Million (2013-2018)
  • Table 47. Netherlands Retail Drug, by Application USD Million (2013-2018)
  • Table 48. Rest of Europe Retail Drug, by Type USD Million (2013-2018)
  • Table 49. Rest of Europe Retail Drug, by Application USD Million (2013-2018)
  • Table 50. MEA Retail Drug, by Country USD Million (2013-2018)
  • Table 51. MEA Retail Drug, by Type USD Million (2013-2018)
  • Table 52. MEA Retail Drug, by Application USD Million (2013-2018)
  • Table 53. Middle East Retail Drug, by Type USD Million (2013-2018)
  • Table 54. Middle East Retail Drug, by Application USD Million (2013-2018)
  • Table 55. Africa Retail Drug, by Type USD Million (2013-2018)
  • Table 56. Africa Retail Drug, by Application USD Million (2013-2018)
  • Table 57. North America Retail Drug, by Country USD Million (2013-2018)
  • Table 58. North America Retail Drug, by Type USD Million (2013-2018)
  • Table 59. North America Retail Drug, by Application USD Million (2013-2018)
  • Table 60. United States Retail Drug, by Type USD Million (2013-2018)
  • Table 61. United States Retail Drug, by Application USD Million (2013-2018)
  • Table 62. Canada Retail Drug, by Type USD Million (2013-2018)
  • Table 63. Canada Retail Drug, by Application USD Million (2013-2018)
  • Table 64. Mexico Retail Drug, by Type USD Million (2013-2018)
  • Table 65. Mexico Retail Drug, by Application USD Million (2013-2018)
  • Table 66. Retail Drug Sales: by Type(k Tons)
  • Table 67. Retail Drug Sales Generic Drug , by Region k Tons (2013-2018)
  • Table 68. Retail Drug Sales OTC Drug , by Region k Tons (2013-2018)
  • Table 69. Retail Drug Sales Others , by Region k Tons (2013-2018)
  • Table 70. Retail Drug Sales: by Application(k Tons)
  • Table 71. Retail Drug Sales Hospital , by Region k Tons (2013-2018)
  • Table 72. Retail Drug Sales Clinic , by Region k Tons (2013-2018)
  • Table 73. Retail Drug Sales Hoem Use , by Region k Tons (2013-2018)
  • Table 74. South America Retail Drug Sales, by Country k Tons (2013-2018)
  • Table 75. South America Retail Drug Sales, by Type k Tons (2013-2018)
  • Table 76. South America Retail Drug Sales, by Application k Tons (2013-2018)
  • Table 77. Brazil Retail Drug Sales, by Type k Tons (2013-2018)
  • Table 78. Brazil Retail Drug Sales, by Application k Tons (2013-2018)
  • Table 79. Argentina Retail Drug Sales, by Type k Tons (2013-2018)
  • Table 80. Argentina Retail Drug Sales, by Application k Tons (2013-2018)
  • Table 81. Rest of South America Retail Drug Sales, by Type k Tons (2013-2018)
  • Table 82. Rest of South America Retail Drug Sales, by Application k Tons (2013-2018)
  • Table 83. Asia Pacific Retail Drug Sales, by Country k Tons (2013-2018)
  • Table 84. Asia Pacific Retail Drug Sales, by Type k Tons (2013-2018)
  • Table 85. Asia Pacific Retail Drug Sales, by Application k Tons (2013-2018)
  • Table 86. China Retail Drug Sales, by Type k Tons (2013-2018)
  • Table 87. China Retail Drug Sales, by Application k Tons (2013-2018)
  • Table 88. Japan Retail Drug Sales, by Type k Tons (2013-2018)
  • Table 89. Japan Retail Drug Sales, by Application k Tons (2013-2018)
  • Table 90. India Retail Drug Sales, by Type k Tons (2013-2018)
  • Table 91. India Retail Drug Sales, by Application k Tons (2013-2018)
  • Table 92. South Korea Retail Drug Sales, by Type k Tons (2013-2018)
  • Table 93. South Korea Retail Drug Sales, by Application k Tons (2013-2018)
  • Table 94. Taiwan Retail Drug Sales, by Type k Tons (2013-2018)
  • Table 95. Taiwan Retail Drug Sales, by Application k Tons (2013-2018)
  • Table 96. Australia Retail Drug Sales, by Type k Tons (2013-2018)
  • Table 97. Australia Retail Drug Sales, by Application k Tons (2013-2018)
  • Table 98. Rest of Asia-Pacific Retail Drug Sales, by Type k Tons (2013-2018)
  • Table 99. Rest of Asia-Pacific Retail Drug Sales, by Application k Tons (2013-2018)
  • Table 100. Europe Retail Drug Sales, by Country k Tons (2013-2018)
  • Table 101. Europe Retail Drug Sales, by Type k Tons (2013-2018)
  • Table 102. Europe Retail Drug Sales, by Application k Tons (2013-2018)
  • Table 103. Germany Retail Drug Sales, by Type k Tons (2013-2018)
  • Table 104. Germany Retail Drug Sales, by Application k Tons (2013-2018)
  • Table 105. France Retail Drug Sales, by Type k Tons (2013-2018)
  • Table 106. France Retail Drug Sales, by Application k Tons (2013-2018)
  • Table 107. Italy Retail Drug Sales, by Type k Tons (2013-2018)
  • Table 108. Italy Retail Drug Sales, by Application k Tons (2013-2018)
  • Table 109. United Kingdom Retail Drug Sales, by Type k Tons (2013-2018)
  • Table 110. United Kingdom Retail Drug Sales, by Application k Tons (2013-2018)
  • Table 111. Netherlands Retail Drug Sales, by Type k Tons (2013-2018)
  • Table 112. Netherlands Retail Drug Sales, by Application k Tons (2013-2018)
  • Table 113. Rest of Europe Retail Drug Sales, by Type k Tons (2013-2018)
  • Table 114. Rest of Europe Retail Drug Sales, by Application k Tons (2013-2018)
  • Table 115. MEA Retail Drug Sales, by Country k Tons (2013-2018)
  • Table 116. MEA Retail Drug Sales, by Type k Tons (2013-2018)
  • Table 117. MEA Retail Drug Sales, by Application k Tons (2013-2018)
  • Table 118. Middle East Retail Drug Sales, by Type k Tons (2013-2018)
  • Table 119. Middle East Retail Drug Sales, by Application k Tons (2013-2018)
  • Table 120. Africa Retail Drug Sales, by Type k Tons (2013-2018)
  • Table 121. Africa Retail Drug Sales, by Application k Tons (2013-2018)
  • Table 122. North America Retail Drug Sales, by Country k Tons (2013-2018)
  • Table 123. North America Retail Drug Sales, by Type k Tons (2013-2018)
  • Table 124. North America Retail Drug Sales, by Application k Tons (2013-2018)
  • Table 125. United States Retail Drug Sales, by Type k Tons (2013-2018)
  • Table 126. United States Retail Drug Sales, by Application k Tons (2013-2018)
  • Table 127. Canada Retail Drug Sales, by Type k Tons (2013-2018)
  • Table 128. Canada Retail Drug Sales, by Application k Tons (2013-2018)
  • Table 129. Mexico Retail Drug Sales, by Type k Tons (2013-2018)
  • Table 130. Mexico Retail Drug Sales, by Application k Tons (2013-2018)
  • Table 131. Retail Drug: by Type(USD/Units)
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. Company Basic Information, Sales Area and Its Competitors
  • Table 143. Retail Drug: by Type(USD Million)
  • Table 144. Retail Drug Generic Drug , by Region USD Million (2019-2024)
  • Table 145. Retail Drug OTC Drug , by Region USD Million (2019-2024)
  • Table 146. Retail Drug Others , by Region USD Million (2019-2024)
  • Table 147. Retail Drug: by Application(USD Million)
  • Table 148. Retail Drug Hospital , by Region USD Million (2019-2024)
  • Table 149. Retail Drug Clinic , by Region USD Million (2019-2024)
  • Table 150. Retail Drug Hoem Use , by Region USD Million (2019-2024)
  • Table 151. South America Retail Drug, by Country USD Million (2019-2024)
  • Table 152. South America Retail Drug, by Type USD Million (2019-2024)
  • Table 153. South America Retail Drug, by Application USD Million (2019-2024)
  • Table 154. Brazil Retail Drug, by Type USD Million (2019-2024)
  • Table 155. Brazil Retail Drug, by Application USD Million (2019-2024)
  • Table 156. Argentina Retail Drug, by Type USD Million (2019-2024)
  • Table 157. Argentina Retail Drug, by Application USD Million (2019-2024)
  • Table 158. Rest of South America Retail Drug, by Type USD Million (2019-2024)
  • Table 159. Rest of South America Retail Drug, by Application USD Million (2019-2024)
  • Table 160. Asia Pacific Retail Drug, by Country USD Million (2019-2024)
  • Table 161. Asia Pacific Retail Drug, by Type USD Million (2019-2024)
  • Table 162. Asia Pacific Retail Drug, by Application USD Million (2019-2024)
  • Table 163. China Retail Drug, by Type USD Million (2019-2024)
  • Table 164. China Retail Drug, by Application USD Million (2019-2024)
  • Table 165. Japan Retail Drug, by Type USD Million (2019-2024)
  • Table 166. Japan Retail Drug, by Application USD Million (2019-2024)
  • Table 167. India Retail Drug, by Type USD Million (2019-2024)
  • Table 168. India Retail Drug, by Application USD Million (2019-2024)
  • Table 169. South Korea Retail Drug, by Type USD Million (2019-2024)
  • Table 170. South Korea Retail Drug, by Application USD Million (2019-2024)
  • Table 171. Taiwan Retail Drug, by Type USD Million (2019-2024)
  • Table 172. Taiwan Retail Drug, by Application USD Million (2019-2024)
  • Table 173. Australia Retail Drug, by Type USD Million (2019-2024)
  • Table 174. Australia Retail Drug, by Application USD Million (2019-2024)
  • Table 175. Rest of Asia-Pacific Retail Drug, by Type USD Million (2019-2024)
  • Table 176. Rest of Asia-Pacific Retail Drug, by Application USD Million (2019-2024)
  • Table 177. Europe Retail Drug, by Country USD Million (2019-2024)
  • Table 178. Europe Retail Drug, by Type USD Million (2019-2024)
  • Table 179. Europe Retail Drug, by Application USD Million (2019-2024)
  • Table 180. Germany Retail Drug, by Type USD Million (2019-2024)
  • Table 181. Germany Retail Drug, by Application USD Million (2019-2024)
  • Table 182. France Retail Drug, by Type USD Million (2019-2024)
  • Table 183. France Retail Drug, by Application USD Million (2019-2024)
  • Table 184. Italy Retail Drug, by Type USD Million (2019-2024)
  • Table 185. Italy Retail Drug, by Application USD Million (2019-2024)
  • Table 186. United Kingdom Retail Drug, by Type USD Million (2019-2024)
  • Table 187. United Kingdom Retail Drug, by Application USD Million (2019-2024)
  • Table 188. Netherlands Retail Drug, by Type USD Million (2019-2024)
  • Table 189. Netherlands Retail Drug, by Application USD Million (2019-2024)
  • Table 190. Rest of Europe Retail Drug, by Type USD Million (2019-2024)
  • Table 191. Rest of Europe Retail Drug, by Application USD Million (2019-2024)
  • Table 192. MEA Retail Drug, by Country USD Million (2019-2024)
  • Table 193. MEA Retail Drug, by Type USD Million (2019-2024)
  • Table 194. MEA Retail Drug, by Application USD Million (2019-2024)
  • Table 195. Middle East Retail Drug, by Type USD Million (2019-2024)
  • Table 196. Middle East Retail Drug, by Application USD Million (2019-2024)
  • Table 197. Africa Retail Drug, by Type USD Million (2019-2024)
  • Table 198. Africa Retail Drug, by Application USD Million (2019-2024)
  • Table 199. North America Retail Drug, by Country USD Million (2019-2024)
  • Table 200. North America Retail Drug, by Type USD Million (2019-2024)
  • Table 201. North America Retail Drug, by Application USD Million (2019-2024)
  • Table 202. United States Retail Drug, by Type USD Million (2019-2024)
  • Table 203. United States Retail Drug, by Application USD Million (2019-2024)
  • Table 204. Canada Retail Drug, by Type USD Million (2019-2024)
  • Table 205. Canada Retail Drug, by Application USD Million (2019-2024)
  • Table 206. Mexico Retail Drug, by Type USD Million (2019-2024)
  • Table 207. Mexico Retail Drug, by Application USD Million (2019-2024)
  • Table 208. Retail Drug Sales: by Type(k Tons)
  • Table 209. Retail Drug Sales Generic Drug , by Region k Tons (2019-2024)
  • Table 210. Retail Drug Sales OTC Drug , by Region k Tons (2019-2024)
  • Table 211. Retail Drug Sales Others , by Region k Tons (2019-2024)
  • Table 212. Retail Drug Sales: by Application(k Tons)
  • Table 213. Retail Drug Sales Hospital , by Region k Tons (2019-2024)
  • Table 214. Retail Drug Sales Clinic , by Region k Tons (2019-2024)
  • Table 215. Retail Drug Sales Hoem Use , by Region k Tons (2019-2024)
  • Table 216. South America Retail Drug Sales, by Country k Tons (2019-2024)
  • Table 217. South America Retail Drug Sales, by Type k Tons (2019-2024)
  • Table 218. South America Retail Drug Sales, by Application k Tons (2019-2024)
  • Table 219. Brazil Retail Drug Sales, by Type k Tons (2019-2024)
  • Table 220. Brazil Retail Drug Sales, by Application k Tons (2019-2024)
  • Table 221. Argentina Retail Drug Sales, by Type k Tons (2019-2024)
  • Table 222. Argentina Retail Drug Sales, by Application k Tons (2019-2024)
  • Table 223. Rest of South America Retail Drug Sales, by Type k Tons (2019-2024)
  • Table 224. Rest of South America Retail Drug Sales, by Application k Tons (2019-2024)
  • Table 225. Asia Pacific Retail Drug Sales, by Country k Tons (2019-2024)
  • Table 226. Asia Pacific Retail Drug Sales, by Type k Tons (2019-2024)
  • Table 227. Asia Pacific Retail Drug Sales, by Application k Tons (2019-2024)
  • Table 228. China Retail Drug Sales, by Type k Tons (2019-2024)
  • Table 229. China Retail Drug Sales, by Application k Tons (2019-2024)
  • Table 230. Japan Retail Drug Sales, by Type k Tons (2019-2024)
  • Table 231. Japan Retail Drug Sales, by Application k Tons (2019-2024)
  • Table 232. India Retail Drug Sales, by Type k Tons (2019-2024)
  • Table 233. India Retail Drug Sales, by Application k Tons (2019-2024)
  • Table 234. South Korea Retail Drug Sales, by Type k Tons (2019-2024)
  • Table 235. South Korea Retail Drug Sales, by Application k Tons (2019-2024)
  • Table 236. Taiwan Retail Drug Sales, by Type k Tons (2019-2024)
  • Table 237. Taiwan Retail Drug Sales, by Application k Tons (2019-2024)
  • Table 238. Australia Retail Drug Sales, by Type k Tons (2019-2024)
  • Table 239. Australia Retail Drug Sales, by Application k Tons (2019-2024)
  • Table 240. Rest of Asia-Pacific Retail Drug Sales, by Type k Tons (2019-2024)
  • Table 241. Rest of Asia-Pacific Retail Drug Sales, by Application k Tons (2019-2024)
  • Table 242. Europe Retail Drug Sales, by Country k Tons (2019-2024)
  • Table 243. Europe Retail Drug Sales, by Type k Tons (2019-2024)
  • Table 244. Europe Retail Drug Sales, by Application k Tons (2019-2024)
  • Table 245. Germany Retail Drug Sales, by Type k Tons (2019-2024)
  • Table 246. Germany Retail Drug Sales, by Application k Tons (2019-2024)
  • Table 247. France Retail Drug Sales, by Type k Tons (2019-2024)
  • Table 248. France Retail Drug Sales, by Application k Tons (2019-2024)
  • Table 249. Italy Retail Drug Sales, by Type k Tons (2019-2024)
  • Table 250. Italy Retail Drug Sales, by Application k Tons (2019-2024)
  • Table 251. United Kingdom Retail Drug Sales, by Type k Tons (2019-2024)
  • Table 252. United Kingdom Retail Drug Sales, by Application k Tons (2019-2024)
  • Table 253. Netherlands Retail Drug Sales, by Type k Tons (2019-2024)
  • Table 254. Netherlands Retail Drug Sales, by Application k Tons (2019-2024)
  • Table 255. Rest of Europe Retail Drug Sales, by Type k Tons (2019-2024)
  • Table 256. Rest of Europe Retail Drug Sales, by Application k Tons (2019-2024)
  • Table 257. MEA Retail Drug Sales, by Country k Tons (2019-2024)
  • Table 258. MEA Retail Drug Sales, by Type k Tons (2019-2024)
  • Table 259. MEA Retail Drug Sales, by Application k Tons (2019-2024)
  • Table 260. Middle East Retail Drug Sales, by Type k Tons (2019-2024)
  • Table 261. Middle East Retail Drug Sales, by Application k Tons (2019-2024)
  • Table 262. Africa Retail Drug Sales, by Type k Tons (2019-2024)
  • Table 263. Africa Retail Drug Sales, by Application k Tons (2019-2024)
  • Table 264. North America Retail Drug Sales, by Country k Tons (2019-2024)
  • Table 265. North America Retail Drug Sales, by Type k Tons (2019-2024)
  • Table 266. North America Retail Drug Sales, by Application k Tons (2019-2024)
  • Table 267. United States Retail Drug Sales, by Type k Tons (2019-2024)
  • Table 268. United States Retail Drug Sales, by Application k Tons (2019-2024)
  • Table 269. Canada Retail Drug Sales, by Type k Tons (2019-2024)
  • Table 270. Canada Retail Drug Sales, by Application k Tons (2019-2024)
  • Table 271. Mexico Retail Drug Sales, by Type k Tons (2019-2024)
  • Table 272. Mexico Retail Drug Sales, by Application k Tons (2019-2024)
  • Table 273. Retail Drug: by Type(USD/Units)
  • Table 274. Research Programs/Design for This Report
  • Table 275. Key Data Information from Secondary Sources
  • Table 276. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Retail Drug: by Type USD Million (2013-2018)
  • Figure 5. Global Retail Drug: by Application USD Million (2013-2018)
  • Figure 6. South America Retail Drug Share (%), by Country
  • Figure 7. Asia Pacific Retail Drug Share (%), by Country
  • Figure 8. Europe Retail Drug Share (%), by Country
  • Figure 9. MEA Retail Drug Share (%), by Country
  • Figure 10. North America Retail Drug Share (%), by Country
  • Figure 11. Global Retail Drug: by Type k Tons (2013-2018)
  • Figure 12. Global Retail Drug: by Application k Tons (2013-2018)
  • Figure 13. South America Retail Drug Share (%), by Country
  • Figure 14. Asia Pacific Retail Drug Share (%), by Country
  • Figure 15. Europe Retail Drug Share (%), by Country
  • Figure 16. MEA Retail Drug Share (%), by Country
  • Figure 17. North America Retail Drug Share (%), by Country
  • Figure 18. Global Retail Drug: by Type USD/Units (2013-2018)
  • Figure 19. Global Retail Drug share by Players 2018 (%)
  • Figure 20. Global Retail Drug share by Players (Top 3) 2018(%)
  • Figure 21. Global Retail Drug share by Players (Top 5) 2018(%)
  • Figure 22. BCG Matrix for key Companies
  • Figure 23. CVS Caremark (United States) Revenue, Net Income and Gross profit
  • Figure 24. CVS Caremark (United States) Revenue: by Geography 2018
  • Figure 25. Rite Aid (United States) Revenue, Net Income and Gross profit
  • Figure 26. Rite Aid (United States) Revenue: by Geography 2018
  • Figure 27. Target Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 28. Target Corporation (United States) Revenue: by Geography 2018
  • Figure 29. Walgreens (United States) Revenue, Net Income and Gross profit
  • Figure 30. Walgreens (United States) Revenue: by Geography 2018
  • Figure 31. Walmart (United States) Revenue, Net Income and Gross profit
  • Figure 32. Walmart (United States) Revenue: by Geography 2018
  • Figure 33. Health Mart Pharmacy (United States) Revenue, Net Income and Gross profit
  • Figure 34. Health Mart Pharmacy (United States) Revenue: by Geography 2018
  • Figure 35. The Kroger Co. (United States) Revenue, Net Income and Gross profit
  • Figure 36. The Kroger Co. (United States) Revenue: by Geography 2018
  • Figure 37. Good Neighbor Pharmacy (United States) Revenue, Net Income and Gross profit
  • Figure 38. Good Neighbor Pharmacy (United States) Revenue: by Geography 2018
  • Figure 39. Safeway Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 40. Safeway Inc. (United States) Revenue: by Geography 2018
  • Figure 41. Kmart Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 42. Kmart Corporation (United States) Revenue: by Geography 2018
  • Figure 43. Hy-Vee (United States) Revenue, Net Income and Gross profit
  • Figure 44. Hy-Vee (United States) Revenue: by Geography 2018
  • Figure 45. Global Retail Drug: by Type USD Million (2019-2024)
  • Figure 46. Global Retail Drug: by Application USD Million (2019-2024)
  • Figure 47. South America Retail Drug Share (%), by Country
  • Figure 48. Asia Pacific Retail Drug Share (%), by Country
  • Figure 49. Europe Retail Drug Share (%), by Country
  • Figure 50. MEA Retail Drug Share (%), by Country
  • Figure 51. North America Retail Drug Share (%), by Country
  • Figure 52. Global Retail Drug: by Type k Tons (2019-2024)
  • Figure 53. Global Retail Drug: by Application k Tons (2019-2024)
  • Figure 54. South America Retail Drug Share (%), by Country
  • Figure 55. Asia Pacific Retail Drug Share (%), by Country
  • Figure 56. Europe Retail Drug Share (%), by Country
  • Figure 57. MEA Retail Drug Share (%), by Country
  • Figure 58. North America Retail Drug Share (%), by Country
  • Figure 59. Global Retail Drug: by Type USD/Units (2019-2024)
Some of the key companies/manufacturers profiled in the report
  • CVS Caremark (United States)
  • Rite Aid (United States)
  • Target Corporation (United States)
  • Walgreens (United States)
  • Walmart (United States)
  • Health Mart Pharmacy (United States)
  • The Kroger Co. (United States)
  • Good Neighbor Pharmacy (United States)
  • Safeway Inc. (United States)
  • Kmart Corporation (United States)
  • Hy-Vee (United States)
Additional players considered in the study are as follows:
Giant Eagl (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation